ANOVA PANCAN result package
Francesco Iorio, EMBL - European Bioinformatics Institute
result parsing started on 2016-03-31 19:01:09 iorio@ebi.ac.uk
Drug Domain: GDSC1000_paper_set, Analysis Domain: panCancer
Individual drug analysis: 94
Drug details and screening numbers
Drug Name: TGX221
Drug ID: 94
Synonyms:
Brand name:
Target: PI3Kbeta
Number of cell lines screened: 401
Screening concentration range(s): 0.0390625 to 10 uM
Statistically significant associations identified = 2
association id |
FEATURE |
Drug id |
Propr |
Public |
Drug Name |
Drug Target |
N FEATURE pos |
N FEATURE neg |
log max Conc tested |
FEATURE neg logIC50 MEAN |
FEATURE pos logIC50 MEAN |
FEATURE deltaMEAN IC50 |
FEATURE IC50 effectSize |
FEATURE neg Glass delta |
FEATURE pos Glass delta |
ANOVA FEATURE pval |
Tissue ANOVA pval |
MSI ANOVA pval |
ANOVA FEATURE FDR % |
a147 |
HRAS_mut |
94 |
1 |
1 |
TGX221 |
PI3Kbeta |
3 |
397 |
2.3 |
3.84 |
1.68 |
-2.16 |
1.9 * |
1.9 * |
0.6 . |
3.62e-05 |
8.96e-14 |
6.65e-01 |
4.1 |
a164 |
NFE2L2_mut |
94 |
1 |
1 |
TGX221 |
PI3Kbeta |
3 |
397 |
2.3 |
3.84 |
1.74 |
-2.1 |
1.8 * |
1.9 * |
0.56 . |
5.24e-05 |
9.67e-14 |
6.65e-01 |
5.2 |
All-tests volcano plot